Literature DB >> 3504554

Computed tomographic findings in progressive supranuclear palsy: correlation with clinical grade.

S M Schonfeld1, L I Golbe, J I Sage, J N Safer, R C Duvoisin.   

Abstract

We report clinical and computed tomography (CT) findings in 17 patients with progressive supranuclear palsy (PSP). Patients were divided into four clinical groups according to the severity of the disease and functional disability. In Grade 1, patients demonstrated minor disability and decreased anteroposterior (AP) diameter of the midbrain tegmentum was present. As the disease progressed clinically to Grade 2, more severe atrophy of the pons and midbrain and dilatation of the quadrigeminal plate cistern were noted. The most severe stages of clinical disability (Grades 3 and 4) were characterized radiologically by dilatation of the aqueduct, progressive dilatation of the third and fourth ventricles and atrophy of the temporal lobes. Cortical atrophy was variable and not a prominent radiological feature. Midbrain and pontine AP diameters were significantly smaller in PSP patients than normal patients. Serial studies showed progressive involution of the pons and midbrain and enlargement of the third ventricle. While the most obvious CT changes in PSP occur late in the disease, CT may in fact suggest the correct diagnosis long before the classic clinical picture is evident.

Entities:  

Mesh:

Year:  1987        PMID: 3504554     DOI: 10.1002/mds.870020404

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  7 in total

Review 1.  Progressive supranuclear palsy: clinical features, pathophysiology and management.

Authors:  A Rajput; A H Rajput
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

2.  Midbrain atrophy in vascular Parkinsonism.

Authors:  Seong-Min Choi; Byeong C Kim; Tai-Seung Nam; Joon-Tae Kim; Seung-Han Lee; Man-Seok Park; Myeong-Kyu Kim; Mony J de Leon; Ki-Hyun Cho
Journal:  Eur Neurol       Date:  2011-04-21       Impact factor: 1.710

3.  Is MRPI 2.0 More Useful than MRPI and M/P Ratio in Differential Diagnosis of PSP-P with Other Atypical Parkinsonisms?

Authors:  Natalia Madetko; Piotr Alster; Michał Kutyłowski; Bartosz Migda; Michał Nieciecki; Dariusz Koziorowski; Leszek Królicki
Journal:  J Clin Med       Date:  2022-05-10       Impact factor: 4.964

4.  Progressive supranuclear palsy: MRI and pathological findings.

Authors:  A Yagishita; M Oda
Journal:  Neuroradiology       Date:  1996-05       Impact factor: 2.804

5.  Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study.

Authors:  I Litvan; C A Mangone; A McKee; M Verny; A Parsa; K Jellinger; L D'Olhaberriague; K R Chaudhuri; R K Pearce
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

6.  Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.

Authors:  N L Foster; S Gilman; S Berent; A A Sima; C D'Amato; R A Koeppe; S P Hicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

7.  The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes.

Authors:  Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman
Journal:  Diagnostics (Basel)       Date:  2022-07-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.